Company Limited (“the Company”) would like to clarify the operating results of the Company and its subsidiary for the first quarter ended March 31, 2019 which has been audited by the independent auditor as

/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

Puri Power (Thailand) Co.,Ltd. SAFE invest in Bina 49.00% and SAFE Biomass Co.,Ltd. SAFE invest in SAFE Biomass Co.,Ltd. 100.00%. The Company shall recognize the sharing of operating performance total

Public Company Limited ( “ the Company” ) would like to clarify the operating results of the Company and its subsidiary for the 3rd quarter ended September 30, 2019 which has been audited by the

mainly from higher operating cost from new further processing factory. Financial Costs Financial costs of the group include the interest paid to financial institutions and related persons. The Company’s

the slowdown of the market. Hence, there Q1/19 production will be low comparing to other quarter. Executive Summary The company's operating results in the year 2018 has significantly increased both

shut down early to February due to the slowdown of the market. Hence, there Q1/19 production will be low comparing to other quarter. Executive Summary The company's operating results in the year 2018 has

(used in) operating activities 876 213 76% Cash flows from investing activities Interest received 2 2 (33%) Purchase of property, plant and equipment (31) (6) 79% Purchase of intangible assets (2) (0) 89

% down comparing to 2Q2017 mainly from higher operating cost from new further processing factory. The consolidated share of loss from associated companies for 6M2018 was THB 66.92 million, rose by THB